针对中链乙基-CoA脱酶 (MCAD) 的基因疗法无法预防糖尿病诱导的心脏病理
Kate L Weeks1,2,3, Helen Kiriazis2,4, Glenn D Wadley5
1Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC, 3010, Australia.
概括
增加中链乙辅酶A脱酶 (MCAD) 表达并没有改善糖尿病人的心脏功能. 糖尿病心脏中腺相关病毒载体吸收的减少影响了糖尿病心肌病的潜在AAV疗法.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 糖尿病心肌病是一种糖尿病并发症,导致心力衰竭.
- 失调的心脏能量代谢是糖尿病心肌病进展的关键因素.
- 目前糖尿病心脏病的治疗方法有限.
研究的目的:
- 调查是否增加中链乙辅酶A脱酶 (MCAD) 表达能改善糖尿病人的心脏功能.
- 在糖尿病小鼠模型中评估MCAD对心脏代谢和病理学的影响.
主要方法:
- 在雄性小鼠中,使用链毒素诱导糖尿病.
- 选择性心脏腺相关病毒载体编码MCAD (rAAV6:MCAD) 被管理.
- 分析了心脏功能,基因表达,蛋白质水平和代谢标志物.
主要成果:
- 在非糖尿病心脏中,rAAV6:MCAD增加了MCAD mRNA和蛋白质,但不是酶活性.
- 在糖尿病心脏中,MCAD基因传递增加了mRNA,但不是蛋白质或活性.
- MCAD基因传递没有改善糖尿病诱导的心脏病理或代谢标志物.
- 与非糖尿病心脏相比,糖尿病心脏中腺相关的病毒载体吸收减少.
结论:
- 仅仅增加心脏MCAD基因表达就不足以防止糖尿病引起的心脏病理.
- 糖尿病心脏中AAV转导效率降低对基于AAV的治疗策略构成了挑战.
- 需要进一步的研究来探索糖尿病心肌病的替代或联合治疗方法.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


